A class action suit has been proposed against Highmark Inc. arguing the company conspired with the University of Pittsburgh Medical Center to fix insurance rates. Highmark Inc. has responded by arguing the suit cannot go forward, citing a U.S. Supreme Court ruling that says damages cannot be awarded over charges involving anti-competitive behavior in rate pricing if those rate have already been approved by a regulation authority. A strategic partnership between Highmark Inc. and St. Vincent Health System had been agreed upon earlier last month in an effort for Highmark to become a stronger competitor against University of Pittsburgh Medical Center.
Full Content: Law360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan